• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CARTIVA, INC CARTIVA IMPLANT; PROSTHESIS, METATARSOPHALANGEAL JOINT CARTILAGE REPLACEMENT IMPLANT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CARTIVA, INC CARTIVA IMPLANT; PROSTHESIS, METATARSOPHALANGEAL JOINT CARTILAGE REPLACEMENT IMPLANT Back to Search Results
Medical Device Problem Codes Fracture (1260); Loosening of Implant Not Related to Bone-Ingrowth (4002); Migration (4003)
Health Effect - Clinical Codes Unspecified Infection (1930); Inflammation (1932); Pain (1994); Swelling/ Edema (4577)
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Literature citation: metikala et al.Adverse events related to polyvinyl alcohol hydrogel hemiarthroplasty of 1st metatarsal: an analysis of reports to the united states food and drug administration.Foot & ankle orthopaedics.2020; 5:4.The device was not returned for evaluation.
 
Event or Problem Description
It was reported in a literature article by metikala el al.Titled adverse events related to polyvinyl alcohol hydrogel hemiarthroplasty of 1st metatarsal: an analysis of reports to the united states food and drug administration did a retrospective review of maude database between july 2016 and october 2019 using the assigned product code: pnw for the polyvinyl alcohol hydrogel implant.A total of 49 events have been reported to this voluntary database over the past 3 years while over 22,000 cartiva devices have been implanted.Implant subsidence was the most common with 16 reported instances.Fragmentation of the device was observed in nine and four reports were related to infection in which two were deep infections needing antibiotic spacers.Bone erosion managed by grafting was documented in three reports and foreign body reaction was noted in one.Persistent pain and swelling were common presentations.Thirty-five of 49 reported events required additional operative procedures performed at a mean interval of 4.75 months following the index procedure while four more were awaiting further surgery.Conversion to fusion was the most common procedure, featured in 10 reports.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARTIVA IMPLANT
Common Device Name
PROSTHESIS, METATARSOPHALANGEAL JOINT CARTILAGE REPLACEMENT IMPLANT
Manufacturer (Section D)
CARTIVA, INC
6120 windward parkway
suite 220
alpharetta GA 30005
MDR Report Key11279785
Report Number3009351194-2021-00088
Device Sequence Number4188471
Product Code PNW
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
P150017
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source literature
Initial Reporter Occupation Physician
Type of Report Initial
Report Date (Section B) 01/06/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/06/2021
Initial Report FDA Received Date02/04/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Other; Required Intervention;
-
-